Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-00441

Long-term follow-up of an extreme kinking of a right coronary artery stenosis treated with a bioresorbable vascular scaffold

Florian Basile Stierlin1, MD; Serban Puricel2, MD; Stéphane Cook2, PhD

Figure 1. Pre- and post-treatment coronarography angiogram with OCT findings. A) Coronary angiogram of the right coronary artery showing the stenosis in the middle of a kinking of the distal artery (A1). The angles proximal and distal to the stenosis were >125° in both LAO 30°/cranial 20° (A2) and RAO 30° (A3) views. B) Modifications in vessel geometry immediately after bioresorbable vascular scaffold (BVS) implantation in LAO 30°/cranial 20° view (B1). The angles proximal and distal to the BVS were <90° in both LAO 30°/cranial 20° (B2) and RAO 30° (B3) views. Optical coherence tomography findings post PCI are shown (B4). C) Coronary angiogram of the right coronary artery at four-year follow-up in LAO 30°/cranial 20° view (C1). The angles proximal and distal to the BVS were <110° in both LAO 30°/cranial 20° (C2) and RAO 30° (C3) views. Optical coherence tomography findings at four-year follow-up are shown (C4).

We describe the case of a 68-year-old woman known to have cardiovascular disease who presented with crescendo angina pectoris. The coronary angiogram revealed a tight stenosis of the distal right coronary artery within an extreme kinking (Figure 1A1-Figure 1A3). After adequate lesion preparation with a 2.50/10 mm SC balloon, a 3.00/18 mm Absorb™ bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, CA, USA) was implanted (15 atm, 60 seconds). The immediate angiographic result was good, with improvement in the vessel geometry (Figure 1B1-Figure 1B3) compared to its initial anatomy (Figure 1A1-Figure 1A3). Optical coherence tomography (OCT) confirmed complete stent apposition (Figure 1B4).

Dual antiplatelet therapy consisted of aspirin lifelong and clopidogrel for 12 months. At four-year angiographic follow-up, the result was excellent with modification of the initial kinking to a more physiological anatomy (Figure 1C1-Figure 1C3). OCT confirmed complete BVS resorption (Figure 1C4). At five-year follow-up, the patient was asymptomatic.

Coronary kinking is considered to be one of the most notorious risk factors for stent fracture, encountered in up to 8% of drug-eluting stents (DES)1, and is thought to predispose to in-stent restenosis and stent thrombosis2. No recommendations exist regarding the type of stent to use in extreme kinking stenosis. Although first-generation BVS showed a higher risk of thrombosis in the first two years after implantation3, the risk vanishes with BRS disappearance and artery healing and permits a more physiological anatomy afterwards4. In contrast, metallic stents have a higher resistance to fracture, but the risk increases steadily with each heartbeat. In this case, with actual knowledge, we hypothesised that implanting a BVS instead of a DES would lessen the risk of long-term stent fracture and restore a more physiological vessel anatomy. The long-term clinical, angiographic and OCT results are actually in line with our expectations.

In conclusion, although the attractiveness of the first-generation BVS quickly disappeared, the second-generation BVS could be a suitable option for the treatment of complex anatomic lesions with extreme kinking. More literature is obviously needed in this field.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 15 Number 9
Oct 4, 2019
Volume 15 Number 9
View full issue


Key metrics

On the same subject

IMAGE IN CARDIOLOGY

10.4244/EIJV12I9A89 Oct 20, 2016
Acquired coronary artery aneurysm following treatment with bioresorbable vascular scaffolds
O’Gallagher K et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJ-D-16-00323 Jan 20, 2017
Delayed fracture of a bioresorbable vascular scaffold implanted for in-stent restenosis
Bastante T et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00063 Jan 20, 2021
Late structural discontinuity after bioresorbable vascular scaffold implantation in patients with in-stent restenosis
Cuesta J et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY14M10_07 Nov 20, 2015
Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis
Rivero F et al
free

10.4244/EIJV11I12A259 Mar 18, 2016
Oversized post-dilatation of current bioresorbable vascular scaffolds: kill or cure?
von Birgelen C and Basalus M
free
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved